Cancer testis antigens in myelodysplastic syndromes revisited: a targeted RNA-seq approach
Cancer-Testis antigens (CTA) are named after the tissues where they are mainly expressed: in germinal and in cancer cells, a process that mimics many gametogenesis features. Mapping accurately the CTA gene expression signature in myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (C...
Main Authors: | Ana María Hurtado López, Tzu Hua Chen-Liang, María Zurdo, Salvador Carrillo-Tornel, Joaquín Panadero, Eduardo José Salido, Victor Beltrán, Begoña Muiña, MariLuz Amigo, Noelia Navarro-Villamor, Rosa Cifuentes, Inés Calabria, Ana Isabel Antón, Raúl Teruel, Manuel Muro, Vicente Vicente, Andrés Jerez |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1824642 |
Similar Items
-
PREVENTING INFECTIONS IN HIGHER-RISK MYELODYSPLASTIC SYNDROME PATIENTS TREATED WITH HYPOMETHYLATION AGENTS
by: Yishai Ofran
Published: (2013-08-01) -
Managing myelodysplastic syndromes in very old patients: a teaching case report
by: Niscola P, et al.
Published: (2013-04-01) -
INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY
by: Giuseppe Leone, et al.
Published: (2018-07-01) -
Myelodysplastic syndromes: therapeutic problems and decisions (review)
by: S. V. Semochkin, et al.
Published: (2014-07-01) -
Myelodysplastic syndromes: therapeutic problems and decisions (review)
by: S. V. Semochkin, et al.
Published: (2014-07-01)